Menu
The CardioSCOPE proposal aims to bring together experts from Companies and Αcademia throughout Europe to exchange and expand their expertise on interdisciplinary approaches, to enhance the Research and Innovation capacity of Europe in the field of cardiovascular diseases.
Overall aim of CardioSCOPE is to bring together experts from SMEs and Αcademia throughout Europe to exchange and expand their expertise on interdisciplinary approaches, while enhancing the Research and Innovation capacity of Europe in the field of CVD.
Despite the progress of healthcare systems in the past half of the century, according to the World Health Organization (WHO), cardiovascular diseases (CVDs) are still the number one cause of death worldwide, taking around 17.9 million lives each year (31% of all deaths) and 3.9 million deaths (45% of all deaths) in Europe alone.
These discrepancies between current clinical practices in ACS management and real-life situations underline the need for better characterization of STEMI, NSTEMI and UAP phenotypes and their mechanistic diversity. To develop more patient-oriented and personalized strategies for ACS and MACE management, we need to go beyond the traditional risk factors and one-size-fit-all approach.
Structure (WG Groups)
chair Paolo Magni (UMIL)
vice-chair Iva Perović Blagojević
chair Marco Chierici (FBK)
vice-chair Steven Watterson
chair IRCCSMM Alberico Catapano
vice-chair Giacinto Guercilena (BSN)
chair Christos Tsatsanis (UOC)
vice-chair Maria Vinaixa Crevillent
chair Miron Sopic (PhUOB)
vice-chair Maria Vinaixa Crevillent | Anca Gafencu | Nuria Amigò
chair Nuria Amigò (BT)
vice-chair Jelena Munjas
chair Paolo Magni
vice-chair Miron Sopic
project manager associate Sandra Vladimirov
chair Paolo Magni
vice-chair Miron Sopic
